Xia Jiang

Karolinska Institutet
Country flagSweden

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (18)

Year:

2026

Year:

2026

Objective Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint pain, swelling, and stiffness. Although smoking is a well‐established risk factor for RA, the role of occupational inhalants in RA development is less well recognized. This study aimed to systematically review and synthesize existing evidence on the association between occupational inhalants and the risk of developing RA. Methods We conducted a systematic review and meta‐analysis following the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines, searching MEDLINE, Embase, and Web of Science from database inception to November 20, 2024. Eligible studies were cross‐sectional, were case‐control and cohort designs, were population‐based, reported original data on occupational inhalant exposures and RA, measured exposures, included a comparison group, and used reliable RA ascertainment methods. Studies relying solely on self‐reported RA or focusing on treatment, prognosis, sick leave, or death were excluded. Two reviewers independently conducted literature screening, data extraction, and risk‐of‐bias assessment using the Newcastle–Ottawa Scale. Random‐effects meta‐analyses with relative risk were performed for cohort and case‐control studies, and heterogeneity was assessed using the I 2 statistic. Results In total, 31 studies met inclusion criteria, and 25 were included in meta‐analyses across 10 types of occupational inhalants. Significant associations with RA risk were observed for exposure to silica, asbestos, solvents, pesticides, fertilizers, animal dust, and engine exhaust (relative risks ranging from 1.25 to 1.49). Moderate‐to‐high heterogeneity was observed in seven meta‐analyses. Conclusion Occupational inhalants are associated with increased RA risk, underscoring the importance of workplace prevention strategies and further research into biologic mechanisms.

Year:

2026

Background Adolescence is a critical period for mental health vulnerability alongside rising digital media exposure. Current evidence often fails to distinguish the distinct roles of leisure screen time (LST) quantity and addictive patterns like internet gaming disorder (IGD) on a comprehensive range of mental health outcomes. Objective This study aimed to investigate the independent and joint associations of LST and IGD with multiple mental health conditions among Chinese adolescents. Methods We conducted a school-based, cross-sectional survey in Sichuan Province, China. Participants were recruited by random cluster sampling from 20 public schools. The sample comprised 13,240 adolescents (6659/13,240, 50.3% girls) with a mean age of 15.4 (SD 1.6) years. LST was self-reported, and IGD was evaluated using the Internet Gaming Disorder Scale-9 Item Short Form (IGDS9-SF). Mental health outcomes included overall mental health status and 5 specific diseases: psychological distress, depression, paranoia, insomnia, and suicidal ideation, all assessed using validated scales. Results The prevalence of excessive LST, IGD, and any mental health disorder was 48.2% (6378/13,240; 95% CI 47.3%-49.0%), 1.4% (188/13,240; 95% CI 1.2%-1.6%), and 55.8% (7387/13,240; 95% CI 54.9%-56.7%), respectively. After adjustment, excessive LST (odds ratio [OR] 1.18, 95% CI 1.09-1.27) and IGD (OR 6.58, 95% CI 5.02-8.62) were independently associated with poor mental health. A dose-response relationship existed for LST quartiles (Q2: OR 1.15, 95% CI 1.04-1.26; Q3: OR 1.24, 95% CI 1.12-1.37; Q4: OR 1.31, 95% CI 1.18-1.46; Ptrend<.001). Excessive LST was associated with depression (OR 1.16, 95% CIs 1.05-1.29), paranoia (OR 1.22, 95% CI 1.11-1.34), and suicidal ideation (OR 1.15, 95% CI 1.04-1.28), while IGD was associated with all 5 disorders, most notably depression (OR 6.43, 95% CI 4.56-9.06) and paranoia (OR 5.77, 95% CI 4.05-8.21). IGD consistently demonstrated stronger associations than LST: psychological distress (OR 4.40, 95% CI 3.12-6.19 vs OR 1.14, 95% CI 0.98-1.33), depression (OR 6.43, 95% CI 4.56-9.06 vs OR 1.16, 95% CI 1.05-1.29), paranoia (OR 5.77, 95% CI 4.05-8.21 vs OR 1.22, 95% CI 1.11-1.34), insomnia (OR 2.90, 95% CI 2.09-4.05 vs OR 1.12, 95% CI 102-1.22), and suicidal ideation (OR 3.85, 95% CI 2.76-5.37 vs OR 1.15, 95% CI 1.04-1.28). Adolescents with both excessive LST and IGD demonstrated the highest odds of mental health disorders (OR 7.35, 95% CI 5.29-10.22). No significant interaction was found on additive or multiplicative scales. Conclusions Both excessive LST and IGD are independently associated with mental health disorders in adolescents, with IGD showing a substantially stronger association. This study is distinct from prior research by simultaneously investigating both screen time quantity and addictive usage patterns, and by comprehensively assessing 5 distinct mental health outcomes. Longitudinal studies are needed to better understand the long-term effects.

Year:

2026

Multiple sclerosis (MS) is an immune-mediated disease with no current cure. Drug discovery and repurposing are essential to enhance treatment efficacy and safety. We utilized summary statistics for protein quantitative trait loci (pQTL) of 2,004 plasma and 1,443 brain proteins, a genome-wide association study of MS susceptibility with 14,802 cases and 26,703 controls, both bulk and cell-type specific transcriptome data, and external pQTL data in blood and brain. Our integrative analysis included a proteome-wide association study to identify MS-associated proteins, followed by summary-data-based Mendelian randomization to determine potential causal associations. We used the HEIDI test and Bayesian colocalization analysis to distinguish pleiotropy from linkage. Proteins passing all analyses were prioritized as potential drug targets. We further conducted pathway annotations and protein–protein interaction network analysis (PPI) and verified our findings at mRNA and protein levels. We tested hundreds of MS-associated proteins and confirmed 18 potential causal proteins (nine in plasma and nine in brain). Among these, we found 78 annotated pathways and 16 existing non-MS drugs targeting six proteins. We also identified intricateAQ PPIs among seven potential drug targets and 19 existing MS drug targets, as well as PPIs of four targets across plasma and brain. We identified two targets using bulk mRNA expression data and four targets expressed in MS-related cell types. We finally verified 10 targets using external pQTL data. We prioritized 18 potential drug targets in plasma and brain, elucidating the underlying pathology and providing evidence for potential drug discovery and repurposing in MS.

Year:

2025

Background: The tumor immunosurveillance theory supports that allergic conditions could decrease cancer risk. However, observational evidence yielded inconsistent results for the association between allergic diseases and colorectal cancer risk. We used Mendelian randomization (MR) to examine potential causal associations of allergies with the risk of overall and early-onset colorectal cancer. Methods: Genome-wide association study summary statistical data were used to identify genetic variants associated with allergic diseases (Nvariants = 65) and individual allergic conditions (asthma, hay fever/allergic rhinitis, and eczema). Using two-sample MR, we examined these variants in relation to incident overall (Ncases = 52,775 cases) and early-onset colorectal cancer (Ncases = 6,176). The mediating role of white blood cells was examined using multivariable MR. Results: In inverse-variance–weighted models, genetic liability to allergic diseases was inversely associated with overall {OR per log (odds) = 0.90 [95% confidence interval (CI), 0.85–0.96]; P < 0.01} and early-onset colorectal cancer [OR = 0.83 (95% CI, 0.73–0.95); P = 0.01]. Similar inverse associations were found for hay fever/allergic rhinitis or eczema, whereas no evidence of association was found between liability to asthma-related phenotypes and colorectal cancer risk. Multivariable MR adjustment for eosinophils weakened the inverse associations for liability to allergic diseases for overall [OR = 0.96 (95% CI, 0.89–1.03); P = 0.26] and early-onset colorectal cancer [OR = 0.86 (95% CI, 0.73–1.01); P = 0.06]. Conclusions: Our study supports a potential causal association between liability to allergic diseases, specifically hay fever/allergic rhinitis or eczema, and colorectal cancer, possibly at least in part mediated via eosinophil counts. Impact: Our results provide evidence that allergic responses may also have a role in immunosurveillance against colorectal cancer.

Year:

2025

Background: The coexistence of depression and stroke has long been observed; however, their intrinsic link has not been fully understood. We aimed to inform the importance of depression intervention as a primary prevention of stroke by investigating shared genetic etiology and causal relationship underlying depression and stroke. Methods: Leveraging summary statistics from the hitherto largest genome‐wide association studies (GWAS) in European‐ancestry individuals for depression ( N case / N control = 294,322/741,438) and stroke ( N case / N control = 73,652/1,234,808), we performed cross‐trait linkage‐disequilibrium (LD) score regression and SUPERGNOVA to quantify global and local genetic correlations, cross‐trait meta‐analysis to identify shared genetic loci, transcriptome‐wide association study (TWAS) to detect shared tissue‐specific gene expression, and Mendelian randomization (MR) analysis to make causal inference between the two conditions. Results: We observed a significant positive global genetic correlation between depression and stroke (rg = 0.18, p = 2.92 ×10 −9 ). Partitioning the whole genome, we observed one genomic region (11q23.2) presenting a significant local genetic correlation. Cross‐trait meta‐analysis and TWAS identified two shared genetic loci ( TMEM106B and FES ) revealing potential shared biological mechanisms involving lysosome localization. MR identified a putative causal association of genetically predicted depression on stroke (odds ratio [OR] = 1.13, 95% confidence interval [CI] = 1.07−1.19, p = 1.12 ×10 −5 ). A considerable proportion of this association was mediated through smoking initiation (proportion‐mediated [PM] = 44.0%, 95% CI = 19.9%–68.1%, p = 3.42 ×10 −4 ), hypertension (PM = 34.0%, 95% CI = 14.5%–53.5%, p = 6.46 ×10 −4 ), type 2 diabetes (PM = 19.0%, 95% CI = 8.5%–29.5%, p = 3.78 ×10 −4 ), and atrial fibrillation (PM = 10.9%, 95% CI = 0.7%–21.1%, p = 3.61 ×10 −2 ), respectively. MR in the reverse direction identified a putative association of genetically predicted stroke on depression (OR = 1.05, 95% CI = 1.01−1.09, p = 1.73 ×10 −2 ), which attenuated to nonsignificant when correcting for both correlated and uncorrelated pleiotropy (OR = 1.00, 95% CI = 0.98−1.03, p = 0.88). Drug target MR identified causal associations of genetically predicted TMEM106B level on depression (OR = 0.92, 95% CI = 0.90−0.94, p = 2.04 ×10 −12 ) and stroke (OR = 0.90, 95% CI = 0.86−0.95, p = 3.53 ×10 −5 ). Conclusion: Our work highlights a shared genetic basis and a putative causal relationship between depression and stroke, providing novel insights into the primary prevention of stroke by depression intervention.

Year:

2025

Supplementary Table 7 shows the Mendelian randomization estimates for the potential causal effect of genetic liability to allergic diseases and asthma on colorectal cancer risk; leave one genetic variant out sensitivity analyses.

Year:

2025

Supplementary Table 4 shows the genome-wide significant variants related to (a) allergic diseases (asthma, hay fever, or eczema), (b) early-onset asthma, (c) later-onset asthma, (d) atopic asthma, and (e) hay fever or eczema and their association with other traits in previous genome-wide association studies.

Year:

2025

Supplementary Table 2 shows the genetic variant overlap (same variants or variants in LD R2>0.001 between exposures) for the three exposures tested in our Mendelian randomization analyses (i.e., genetic liability to allergic diseases and their overlap with variants associated with asthma-related phenotypes and hay fever/allergic rhinitis or eczema).

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (21)

Marc Gunter

International Agency for Research on Cancer

FRANCE
View details

Pernilla Stridh

Assistant Professor

Karolinska Institutet

SWEDEN
View details

Emma Vincent

Academic , Professor of Molecular Metabolism

University of Bristol

UNITED KINGDOM
View details

Lina Marcela Diaz-Gallo

Karolinska Institutet

SWEDEN
View details

Zhaozhong Zhu

Massachusetts General Hospital

UNITED STATES
View details

Ingrid Kockum

Research group leader at Karolinska Institutet

Karolinska Institutet

SWEDEN
View details

Wei Zheng

-

UNITED STATES
View details

Elizabeth Platz

Professor

Johns Hopkins University

UNITED STATES
View details

Lars Alfredsson

Professor

Healthcare Provision, Stockholm County

SWEDEN
View details

Sun-Seog Kweon

Chonnam National University

SOUTH KOREA
View details

Robert C. Grant

University Health Network

CANADA
View details

Bethany Van Guelpen

Umea University

SWEDEN
View details

Li Li

University of Virginia

UNITED STATES
View details

Philip Haycock

Senior Lecturer in Cancer Epidemiology

University of Bristol

UNITED KINGDOM
View details

Gianluca Severi

University of Firenze

ITALY
View details

Yung-Han Chang

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Tomas Olsson

Karolinska Institutet

SWEDEN
View details

Daniel D. Buchanan

Senior Research Fellow

University of Melbourne

AUSTRALIA
View details

Shuai Yuan

Karolinska Institutet

SWEDEN
View details

Christopher Li

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Stephen Gruber

Professor

City Of Hope National Medical Center

UNITED STATES
View details